The Effect of Obesity on Simultaneous Bilateral Knee Arthroplasty Surgery

肥胖对双侧膝关节同期置换手术的影响

阅读:1

Abstract

INTRODUCTION: The aim of this study was to evaluate the effect of obesity on clinical outcomes and complications in patients undergoing simultaneous bilateral total knee arthroplasty (SBTKA) based on body mass index criteria. METHODS: Between 2013 and 2020, SBTKA was performed on 795 patients with a mean age of 72 years. After applying exclusion criteria, 776 patients were included in the study. Patients, followed up for an average of 48 months, were categorized by body mass index into two groups: <30 kg/m2 (group I: nonobese) and 30 to 39.9 kg/m2 (group II: obese). Group I consisted of 347 patients while group II included 429 patients. The groups were compared using univariate and multivariate logistic regression analyses for parameters such as length of hospital stay, mobilization time, surgical time, clinical and functional outcomes, prosthetic infection, aseptic loosening, early complications, and wound healing problems. RESULTS: Statistically, there was no significant difference between the groups regarding the incidence of deep vein thrombosis, acute kidney injury, or pulmonary embolism. Statistical analysis revealed that the risk of complications such as aseptic loosening, septic loosening, and medial retinaculum detachment was lower in group I compared with group II. However, univariate and multivariate logistic regression analyses demonstrated no significant differences in overall complications or clinical outcomes between the groups. The only parameters showing significant differences were surgical time, mobilization time, and length of hospital stay. CONCLUSION: We conclude that, when existing comorbidities are taken into account, SBTKA can be safely and successfully performed in obese patients, comparable to nonobese patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。